Benefits
Gut microbiome support
Chitin-glucan is a fermentable fiber: a small human study found a single dose raised colonic fermentation markers, and laboratory colonic-model work shows it shifts gut bacteria. A bifidogenic effect has been seen mainly in laboratory models rather than measured in a human trial.
Digestive tolerability (single-dose study)
A single 4.5 g dose was tolerated without significant digestive discomfort in one small human study; no trial has yet measured whether the fiber improves digestive symptoms or transit.
Cardiometabolic interest
The only human cardiometabolic trial tested a different product, a beta-glucan and chitin-chitosan blend, not chitin-glucan itself, so there is no direct human cardiometabolic evidence for this fiber.
Mechanism of action
Slow colonic fermentation
The insoluble chitin-glucan is fermented gradually along the colon, producing short-chain fatty acids and butyrate that nourish the gut lining.
Bifidogenic activity
In laboratory colonic models, chitin-glucan shifts the microbial community; a selective bifidogenic effect has not been confirmed in a human trial.
Clinical trials
Randomized crossover acute-intervention study comparing a single 4.5 g dose of chitin-glucan against a maltodextrin placebo added to a standardized breakfast, with breath volatile metabolites measured by SIFT-MS across the day. (Neyrinck et al., Gut Microbes, 2021). One co-author is affiliated with KitoZyme, which makes the fiber.
15 healthy volunteers. Single-dose acute crossover.
The 4.5 g dose was tolerated without significant gastrointestinal discomfort and increased exhaled butyrate and other microbial fermentation metabolites, confirming that the fiber is fermented in the colon. This is a fermentation biomarker measured in breath, not a clinical gut-symptom or metabolic outcome.